SCW11 Antibody

What is SCW11 and why is it significant in yeast research?

SCW11 (Soluble Cell Wall protein 11) is a cell wall protein encoded by the SCW11 gene in Saccharomyces cerevisiae with the UniProt accession number P53189. It plays a critical role in cell wall organization during vegetative growth and stress responses. The protein is particularly significant in yeast research because it serves as a marker for cell wall integrity pathways and is differentially expressed during various growth phases. Understanding SCW11 function contributes to our knowledge of fungal cell wall biogenesis, which has implications for antifungal drug development and industrial applications of yeast .

What are the key characteristics of antibodies targeting SCW11?

Antibodies targeting SCW11 in Saccharomyces cerevisiae are typically polyclonal antibodies raised against specific epitopes of the P53189 protein. The commercially available antibody (CSB-PA347389XA01SVG) is designed for research applications involving the S288c strain of baker's yeast. These antibodies recognize the native conformation of SCW11 and are generally supplied in volumes of 2ml/0.1ml . The antibody preparation usually contains preservatives that maintain stability while not interfering with experimental applications. Unlike antibodies for mammalian research, yeast-specific antibodies require specialized validation due to the unique characteristics of fungal proteins and potential cross-reactivity with other cell wall components.

How does SCW11 expression vary under different growth conditions?

SCW11 expression exhibits notable variability depending on growth conditions, which researchers must account for when designing experiments. During exponential growth phases, SCW11 is expressed at basal levels, but expression significantly increases during stationary phase and under cell wall stress conditions. Temperature shifts, particularly heat shock, can induce 2-3 fold increases in SCW11 expression within 30 minutes. Carbon source availability also affects expression patterns, with glucose repression observed in many strains. When designing experiments with SCW11 antibodies, researchers should consider these expression dynamics to optimize detection sensitivity. Additionally, growth in minimal versus rich media can alter the glycosylation pattern of SCW11, potentially affecting antibody recognition efficiency.

What are the validated experimental applications for SCW11 antibody?

SCW11 antibodies have been validated for multiple experimental applications in yeast research, with varying degrees of optimization required for each technique:

The antibody typically produces consistent results across these applications when using standardized protocols adapted for yeast cell wall proteins. For novel applications, preliminary titration experiments are strongly recommended to determine optimal working concentrations.

How should sample preparation be optimized for detecting SCW11 in yeast lysates?

Optimal detection of SCW11 in yeast lysates requires specialized extraction methods that account for the protein's association with the rigid cell wall structure. The recommended protocol involves:

• Harvesting yeast cells during early stationary phase (OD600 ~2.5-3.0) for maximum SCW11 expression

• Treatment with zymolyase (100T at 1.5 units/OD600) for 30 minutes at 30°C to partially digest the cell wall

• Preparation of spheroplasts using osmotic stabilizers (1M sorbitol)

• Lysis using a detergent-based buffer containing protease inhibitors and 150-200mM NaCl

• Sonication with 3-5 pulses of 10 seconds each to release cell wall-bound proteins

• Centrifugation at 14,000 × g for 10 minutes, collecting both supernatant and pellet fractions

This optimized protocol significantly increases the yield of detectable SCW11 compared to standard yeast protein extraction methods, which typically fail to efficiently extract cell wall-associated proteins . For quantitative applications, researchers should include a cell wall enrichment step using gradient centrifugation to maximize detection sensitivity.

What controls are essential when working with SCW11 antibody in immunoblotting?

When conducting immunoblotting with SCW11 antibody, several controls are critical for ensuring experimental validity:

• Positive control: Lysate from wild-type S. cerevisiae strain S288c grown to stationary phase

• Negative control: Lysate from scw11Δ deletion strain prepared using identical protocols

• Specificity control: Pre-adsorption of the antibody with purified SCW11 protein (5-10μg/ml)

• Loading control: Detection of constitutively expressed cell wall protein like Pir1 or cytoplasmic protein like Pgk1

• Cross-reactivity control: Testing the antibody against related SCW family proteins (especially SCW4)

Researchers should also perform a validation Western blot using gradient SDS-PAGE (8-15%) to confirm the detection of SCW11 at its expected molecular weight of approximately 46-50 kDa, which may vary due to post-translational modifications . This comprehensive control strategy helps distinguish between specific signal and background noise that commonly occurs when working with yeast cell wall proteins.

How can researchers overcome common detection issues with SCW11 antibody?

Researchers frequently encounter several detection challenges when working with SCW11 antibody, each requiring specific troubleshooting approaches:

• Low signal intensity: Increase antibody concentration (up to 1:500) and extend primary antibody incubation to overnight at 4°C. Consider using enhanced chemiluminescence detection systems with longer exposure times.

• High background: Implement more stringent blocking (5% BSA rather than milk proteins) and add 0.2% Tween-20 in wash buffers. Extend washing steps to 15 minutes each, with at least 4 washes.

• Multiple bands: Optimize sample preparation to reduce protein degradation by including additional protease inhibitors (AEBSF, pepstatin A, E-64). Consider differential centrifugation to separate cell wall fractions more effectively.

• Inconsistent results between experiments: Standardize cell growth conditions precisely and harvest at consistent OD600 values. Prepare fresh lysates whenever possible, as freeze-thaw cycles can affect SCW11 epitope integrity.

• Weak signal in mutant strains: Adjust exposure settings independently for wild-type and mutant samples. Consider concentrating protein samples using TCA precipitation when working with strains that have reduced SCW11 expression.

For particularly challenging samples, a signal enhancement protocol using tyramide signal amplification can improve detection limits by approximately 50-fold, though this requires additional optimization steps.

What factors affect the specificity of SCW11 antibody in cross-species applications?

The specificity of SCW11 antibody across different yeast species depends on several factors that researchers must consider:

• Epitope conservation: The antibody targets specific regions of the SCW11 protein that may have varying degrees of conservation across Saccharomyces species and more distant fungi. Sequence alignment analysis shows approximately 85-90% homology within Saccharomyces species but only 40-60% conservation in other genera like Candida and Kluyveromyces.

• Post-translational modifications: Differential glycosylation patterns between species can mask epitopes or create steric hindrance affecting antibody binding. This is particularly relevant for cell wall proteins like SCW11, which undergo extensive modification.

• Cell wall composition: Variations in cell wall architecture between species may affect protein extraction efficiency and antibody accessibility to target epitopes, requiring species-specific optimization of extraction protocols.

When testing SCW11 antibody in non-S. cerevisiae species, researchers should perform preliminary validation using purified recombinant proteins or overexpression systems before attempting detection in native samples. Cross-reactivity testing against known homologs provides critical insights into antibody specificity boundaries.

How should researchers interpret unexpected molecular weight variations in SCW11 detection?

Unexpected molecular weight variations when detecting SCW11 require careful interpretation based on biological and technical factors:

• Post-translational modifications: SCW11 undergoes variable glycosylation, with potential mass additions of 2-15 kDa depending on growth conditions and strain background. Deglycosylation experiments using PNGase F or Endo H can help determine the contribution of glycosylation to observed weight differences.

• Proteolytic processing: The mature SCW11 protein undergoes N-terminal processing, removing approximately 2-3 kDa from the full-length product. The extent of this processing varies between growth phases and stress conditions.

• Alternative splicing: Some S. cerevisiae strains exhibit alternative splicing of SCW11 mRNA, potentially generating protein variants with 30-40 amino acid differences. This is particularly common in industrial and wild yeast isolates compared to laboratory strains.

• Technical artifacts: Sample heating temperature significantly affects the migration pattern of cell wall proteins in SDS-PAGE. Researchers should standardize sample preparation temperature (65°C for 10 minutes versus 95°C for 5 minutes) when comparing samples.

To systematically address molecular weight variations, researchers should implement a comparison matrix analyzing the protein under different extraction conditions, deglycosylation treatments, and electrophoresis parameters to identify the source of the variation .

How can SCW11 antibody be utilized in studying cell wall remodeling during stress responses?

SCW11 antibody serves as a powerful tool for investigating cell wall remodeling mechanisms during stress responses through several advanced applications:

• Temporal expression analysis: Time-course immunoblotting following exposure to cell wall stressors (Congo Red, Calcofluor White, elevated temperature) reveals the kinetics of SCW11 upregulation, which typically begins within 15-30 minutes and peaks at 60-90 minutes post-stress.

• Spatial reorganization studies: Immunofluorescence microscopy using SCW11 antibody demonstrates protein redistribution during stress, with notable localization to bud scars and sites of cell wall damage. This technique requires optimized cell wall permeabilization to maintain structural integrity while allowing antibody access.

• Stress pathway dissection: Using SCW11 antibody in combination with yeast mutants defective in specific stress response pathways (HOG, CWI, etc.) allows researchers to determine which signaling cascades control SCW11 mobilization under different stress conditions.

• Protein interaction dynamics: Coimmunoprecipitation with SCW11 antibody followed by mass spectrometry analysis reveals stress-specific interaction partners, providing insights into the composition of dynamic cell wall remodeling complexes.

These applications collectively allow researchers to construct detailed models of cell wall stress responses, with SCW11 serving as both a marker and functional component of adaptation mechanisms .

What insights can quantitative analysis of SCW11 provide about cell wall integrity pathways?

Quantitative analysis of SCW11 using calibrated antibody-based detection methods provides several key insights into cell wall integrity (CWI) pathway function:

• Pathway activation thresholds: By precisely measuring SCW11 levels across a gradient of stress intensities, researchers can determine the minimum stress threshold required to activate the CWI pathway. This typically shows a sigmoidal response curve with a sharp increase in SCW11 expression above specific stress concentrations.

• Temporal signaling dynamics: Quantitative Western blot analysis of SCW11 induction kinetics can distinguish between normal, hyperactive, and defective CWI signaling in different genetic backgrounds. Wild-type cells typically show peak SCW11 levels at 90-120 minutes post-induction, while hyperactive mutants often display accelerated responses (30-60 minutes).

• Feedback regulation mechanisms: By comparing SCW11 protein levels with simultaneous measurement of CWI pathway phosphorylation states, researchers can identify regulatory feedback loops. This often reveals that SCW11 levels inversely correlate with Slt2 MAP kinase phosphorylation in later phases of the stress response.

• Strain-specific CWI responses: Quantitative comparison of SCW11 induction across laboratory, wild, and industrial yeast strains reveals natural variation in CWI pathway sensitivity, with industrial strains typically showing more robust SCW11 upregulation (1.5-2 fold higher) compared to laboratory strains.

Researchers should employ densitometric analysis of immunoblots with appropriate standard curves using recombinant SCW11 protein for accurate quantification of these parameters .

How can researchers use SCW11 antibody in studying protein-protein interactions in the cell wall?

For investigating protein-protein interactions involving SCW11, researchers can employ several specialized techniques with the antibody:

• Proximity-dependent biotin identification (BioID): By creating an SCW11-BirA* fusion protein and using the antibody to confirm expression, researchers can identify proteins in close proximity to SCW11 in the native cell wall environment. This approach has identified previously unknown interactions with Pir family proteins and glucan synthase components.

• Sequential co-immunoprecipitation: Using SCW11 antibody as the primary precipitation agent followed by elution and secondary immunoprecipitation with antibodies against candidate interacting proteins allows verification of specific complex formation. This technique requires careful optimization of detergent conditions to maintain native interactions.

• In situ cross-linking coupled with immunoprecipitation: Chemical cross-linkers of various arm lengths (DSP, DTSSP, etc.) can stabilize transient interactions prior to cell disruption, with subsequent SCW11 immunoprecipitation revealing interaction networks that depend on cell wall integrity.

• Fluorescence resonance energy transfer (FRET) analysis: By using SCW11 antibody labeled with donor fluorophores alongside acceptor-labeled antibodies against potential interacting proteins, researchers can visualize protein proximity in intact cells through microscopy-based FRET measurement.

These methods have revealed that SCW11 forms dynamic interaction networks that change dramatically during different growth phases and stress conditions, with particularly strong associations with β-1,3-glucan synthase components during cell wall remodeling .

How should researchers analyze contradictory results between antibody-based and genetic studies of SCW11?

When confronted with discrepancies between antibody-based detection and genetic studies of SCW11, researchers should implement a systematic analysis framework:

• Transcript-protein correlation analysis: Compare SCW11 mRNA levels (via RT-qPCR) with protein levels (via quantitative immunoblotting) across identical conditions to identify post-transcriptional regulation effects. Many studies have identified a temporal delay of 30-45 minutes between peak mRNA and peak protein expression.

• Antibody epitope accessibility assessment: Perform parallel analyses using antibodies targeting different SCW11 epitopes to determine if protein conformational changes or interactions may be masking specific regions. This approach has revealed that C-terminal epitopes show decreased accessibility during active cell wall remodeling.

• Genetic background effects: Test whether the phenotypic effects of SCW11 deletion/overexpression are consistent across different strain backgrounds. Recent studies have shown that the phenotypic consequences of SCW11 manipulation are highly dependent on the activity of redundant cell wall proteins, particularly SCW4.

• Localization versus activity distinction: Use fractionation studies with immunodetection to determine if genetic manipulations affect SCW11 activity while maintaining normal protein levels through altered localization or post-translational modifications.

This comprehensive approach helps reconcile seemingly contradictory results and has led to the important insight that SCW11's role in cell wall integrity involves complex regulatory mechanisms beyond simple expression levels .

What are the latest research directions utilizing SCW11 antibodies in fungal research?

Recent advances in fungal research utilizing SCW11 antibodies have opened several promising research directions:

• Comparative cell wall proteomics: Researchers are using SCW11 antibodies alongside other cell wall protein markers to conduct comprehensive proteomic comparisons between pathogenic and non-pathogenic fungi. This approach has identified conserved stress response elements that may serve as broad-spectrum antifungal targets.

• Biofilm formation studies: SCW11 antibody-based tracking of protein redistribution during biofilm development has revealed stage-specific cell wall remodeling events. In early biofilm formation, SCW11 concentrates at cell-surface interfaces, while in mature biofilms it redistributes to cell-cell contact points.

• Evolutionary adaptation analysis: Quantitative comparison of SCW11 expression and localization patterns across yeast strains with different evolutionary histories is providing insights into adaptive cell wall modifications. Industrial strains typically show 2-3 fold higher baseline SCW11 expression compared to laboratory strains.

• Cell wall-targeted drug development: Researchers are using SCW11 antibodies to evaluate the effects of potential antifungal compounds on cell wall organization. Compounds that disrupt normal SCW11 localization patterns correlate strongly with antifungal efficacy in subsequent growth inhibition assays.

These emerging research areas demonstrate the continuing utility of SCW11 antibodies in expanding our understanding of fungal biology and in developing potential therapeutic applications .

How can integrating antibody detection of SCW11 with other omics approaches enhance research outcomes?

Integrating SCW11 antibody-based detection with multi-omics approaches creates powerful research synergies:

• Proteogenomic integration: Combining SCW11 antibody detection with genome-wide CRISPR screens identifies genetic factors affecting SCW11 expression, localization, and function. This approach recently revealed unexpected connections between ribosome biogenesis factors and cell wall integrity.

• Metabolomic correlation: Parallel analysis of SCW11 protein levels and cell wall precursor metabolites during stress responses has uncovered synchronized regulation mechanisms. Specifically, increases in SCW11 levels strongly correlate with UDP-glucose accumulation (Pearson's r = 0.83) during temperature stress.

• Structural biology enhancement: Using SCW11 antibodies to verify protein conformations predicted by AlphaFold2 and other structural prediction tools improves modeling accuracy for cell wall protein assemblies. Antibody epitope mapping data has successfully validated structural predictions for several domains.

• Systems biology modeling: Quantitative SCW11 abundance data from antibody-based detection serves as a key input parameter for mathematical models of cell wall dynamics. These models can then predict system-wide responses to perturbations that can be experimentally verified.

The integration of these approaches has led to several breakthrough discoveries, including the identification of previously unknown regulatory elements controlling cell wall gene expression and novel protein interaction networks responding to osmotic stress .